Indian drug regulators say Gennova's COVID-19 vaccine safe in early trials

Indian pharmaceutical firm Gennova Biopharmaceuticals' mRNA-based COVID-19 vaccine was found to be safe and effective in an early-stage study, the country's drug regulator said on Tuesday.

Health authorities have allowed the company to conduct further studies to test the vaccine's efficacy.